Joel Greenblatt Veracyte, Inc. Transaction History

Gotham Asset Management, LLC

$11.5 Billion
Q1 2025

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Veracyte, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 18,881 shares of VCYT stock, worth $509,409. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,881

Previous 20,057 5.86%

Holding current value

$509,409

Previous $794,000 29.6%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$29.65 - $46.14 $34,868 - $54,260	-1,176 Reduced 5.86%	18,881 $559,000
Q4 2024 Feb 14, 2025	BUY	$31.92 - $44.4 $113,284 - $157,575	3,549 Added 21.5%	20,057 $794,000
Q3 2024 Nov 14, 2024	BUY	$21.0 - $35.25 $30,408 - $51,042	1,448 Added 9.61%	16,508 $561,000
Q2 2024 Aug 14, 2024	BUY	$18.86 - $23.55 $87,114 - $108,777	4,619 Added 44.24%	15,060 $326,000
Q1 2024 May 15, 2024	SELL	$21.0 - $29.1 $22,701 - $31,457	-1,081 Reduced 9.38%	10,441 $231,000
Q4 2023 Feb 14, 2024	SELL	$19.72 - $28.68 $666,989 - $970,043	-33,823 Reduced 74.59%	11,522 $316,000
Q3 2023 Nov 14, 2023	BUY	$22.33 - $29.92 $467,389 - $626,255	20,931 Added 85.73%	45,345 $1.01 Million
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $257,619 - $331,734	12,291 Added 101.39%	24,414 $621,000
Q1 2023 May 15, 2023	SELL	$20.58 - $27.89 $1.2 Million - $1.62 Million	-58,092 Reduced 82.73%	12,123 $270,000
Q4 2022 Feb 14, 2023	BUY	$15.31 - $29.94 $623,208 - $1.22 Million	40,706 Added 137.94%	70,215 $1.67 Million
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $15,916 - $26,784	-960 Reduced 3.15%	29,509 $490,000
Q2 2022 Aug 15, 2022	BUY	$15.45 - $29.52 $470,746 - $899,444	30,469 New	30,469 $606,000
Q4 2021 Feb 14, 2022	SELL	$36.09 - $53.79 $1.09 Million - $1.63 Million	-30,299 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$35.62 - $52.97 $1.08 Million - $1.6 Million	30,299 New	30,299 $1.41 Million
Q1 2020 May 15, 2020	SELL	$16.13 - $30.17 $152,751 - $285,709	-9,470 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$20.78 - $29.99 $377,032 - $544,138	-18,144 Reduced 65.71%	9,470 $264,000
Q3 2019 Nov 14, 2019	SELL	$23.87 - $30.93 $86,361 - $111,904	-3,618 Reduced 11.58%	27,614 $663,000
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $690,227 - $891,985	31,232 New	31,232 $890,000

Others Institutions Holding VCYT

# of Institutions

306

Shares Held

79.1M

Call Options Held

15.5K

Put Options Held

16.7K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.93B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account